Skip to main content

Advertisement

Log in

Aneuploidy and elevated CEA indicate an increased risk for metachronous metastasis in colorectal cancer

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Purpose

Presently, no markers exist to predict metachronous metastasis at the time a primary colorectal cancer is diagnosed. While aneuploidy indicates poor survival prognosis and elevated carcinoembryonic antigen (CEA) levels the presence of recurrent disease, the predictive value of both markers regarding imminent metachronous metastases is unclear.

Methods

Sixty patients with distant recurrence throughout a 5-year follow-up (TM+) were randomly chosen and 60 patients without metastasis matched to this cohort (TM−). In addition, an enlarged collective (n = 217; n TM+ = 85, n TM- = 132) with median follow-up of 79.2 months was assessed by logistic regression regarding metachronous metastases. Univariate and stepwise regression analyses included clinicopathological characteristics, preoperative CEA levels and aneuploidy assessed by DNA image cytometry.

Results

The matched-pair collective showed aneuploidy in 71.1 % (TM−) and 85.0 % (TM+; p = 0.076), and elevated CEA in 24.5 % (TM−) and 52.2 % [TM+; odds ratio (OR), 3.414; p = 0.007]. The enlarged collective presented aneuploidy in 71.2 % (TM−) and 83.5 % (TM+; OR 2.050, p = 0.038), and elevated CEA in 28.6 % (TM−) and 48.9 % (TM+; OR 2.391, p = 0.020). Elevated CEA and aneuploidy did not show any association (p = 0.919). In contrast, logistic regression analyses demonstrated that besides increased T category (OR 1.745, p = 0.019), both elevated CEA level (OR 2.633, p = 0.015) and aneuploidy (OR 1.929, p = 0.058) were independent predictive markers for metachronous metastasis.

Conclusions

Our data show that aneuploidy and elevated CEA levels besides increased T category could serve for individual risk assessment to predict metachronous metastases. The fact that still aneuploidy missed the significance level by a small margin emphasizes the need for larger validation studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics, 2008. CA Cancer J Clin 58(2):71–96. doi:10.3322/CA.2007.0010

    Article  PubMed  Google Scholar 

  2. Laubert T, Habermann JK, Hemmelmann C, Kleemann M, Oevermann E, Bouchard R, Hildebrand P, Jungbluth T, Burk C, Esnaashari H, Schloricke E, Hoffmann M, Ziegler A, Bruch HP, Roblick UJ (2012) Metachronous metastasis- and survival-analysis show prognostic importance of lymphadenectomy for colon carcinomas. BMC Gastroenterol 12:24. doi:10.1186/1471-230X-12-24

    Article  PubMed  Google Scholar 

  3. Chuang SC, Su YC, Lu CY, Hsu HT, Sun LC, Shih YL, Ker CG, Hsieh JS, Lee KT, Wang JY (2011) Risk factors for the development of metachronous liver metastasis in colorectal cancer patients after curative resection. World J Surg 35(2):424–429. doi:10.1007/s00268-010-0881-x

    Article  PubMed  Google Scholar 

  4. Stein U, Walther W, Arlt F, Schwabe H, Smith J, Fichtner I, Birchmeier W, Schlag PM (2009) MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med 15(1):59–67. doi:10.1038/nm.1889

    Article  PubMed  CAS  Google Scholar 

  5. Schmiegel W, Reinacher-Schick A, Arnold D, Graeven U, Heinemann V, Porschen R, Riemann J, Rodel C, Sauer R, Wieser M, Schmitt W, Schmoll HJ, Seufferlein T, Kopp I, Pox C (2008) Update S3-guideline "colorectal cancer" 2008. Z Gastroenterol 46(8):799–840. doi:10.1055/s-2008-1027726

    Article  PubMed  CAS  Google Scholar 

  6. Wiratkapun S, Kraemer M, Seow-Choen F, Ho YH, Eu KW (2001) High preoperative serum carcinoembryonic antigen predicts metastatic recurrence in potentially curative colonic cancer: results of a five-year study. Dis Colon Rectum 44(2):231–235

    Article  PubMed  CAS  Google Scholar 

  7. Park IJ, Choi GS, Lim KH, Kang BM, Jun SH (2009) Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level. Ann Surg Oncol 16(11):3087–3093. doi:10.1245/s10434-009-0625-z

    Article  PubMed  Google Scholar 

  8. Araujo SE, Bernardo WM, Habr-Gama A, Kiss DR, Cecconello I (2007) DNA ploidy status and prognosis in colorectal cancer: a meta-analysis of published data. Dis Colon Rectum 50(11):1800–1810. doi:10.1007/s10350-007-9013-6

    Article  PubMed  Google Scholar 

  9. Geigl JB, Obenauf AC, Schwarzbraun T, Speicher MR (2008) Defining 'chromosomal instability'. Trends Genet 24(2):64–69. doi:10.1016/j.tig.2007.11.006

    Article  PubMed  CAS  Google Scholar 

  10. Pino MS, Chung DC (2010) The chromosomal instability pathway in colon cancer. Gastroenterology 138(6):2059–2072. doi:10.1053/j.gastro.2009.12.065

    Article  PubMed  CAS  Google Scholar 

  11. Witzig TE, Loprinzi CL, Gonchoroff NJ, Reiman HM, Cha SS, Wieand HS, Katzmann JA, Paulsen JK, Moertel CG (1991) DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal adenocarcinoma. Cancer 68(4):879–888

    Article  PubMed  CAS  Google Scholar 

  12. Gerling M, Meyer KF, Fuchs K, Igl BW, Fritzsche B, Ziegler A, Bader F, Kujath P, Schimmelpenning H, Bruch HP, Roblick UJ, Habermann JK (2010) High frequency of aneuploidy defines ulcerative colitis-associated carcinomas: a comparative prognostic study to sporadic colorectal carcinomas. Ann Surg. doi:10.1097/SLA.0b013e3181deb664

  13. Lin JK, Chang SC, Yang SH, Jiang JK, Chen WC, Lin TC (2003) Prognostic value of DNA ploidy patterns of colorectal adenocarcinoma. Hepatogastroenterology 50(54):1927–1932

    PubMed  Google Scholar 

  14. Deans GT, Williamson K, Hamilton P, Heatley M, Arthurs K, Patterson CC, Rowlands BJ, Parks TG, Spence RA (1993) DNA densitometry of colorectal cancer. Gut 34(11):1566–1571

    Article  PubMed  CAS  Google Scholar 

  15. Walther A, Houlston R, Tomlinson I (2008) Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis. Gut 57(7):941–950. doi:10.1136/gut.2007.135004

    Article  PubMed  CAS  Google Scholar 

  16. Sun XF (2006) Clinicopathological and biological features of DNA tetraploid colorectal cancers. Cancer J 12(6):501–506

    Article  PubMed  Google Scholar 

  17. Bendardaf R, Lamlum H, Ristamaki R, Algars A, Collan Y, Pyrhonen S (2004) Response to chemotherapy (irinotecan plus 5-fluorouracil) in colorectal carcinoma can be predicted by tumour DNA content. Oncology 66(1):46–52. doi:10.1159/000076334

    Article  PubMed  CAS  Google Scholar 

  18. Armitage NC, Ballantyne KC, Sheffield JP, Clarke P, Evans DF, Hardcastle JD (1991) A prospective evaluation of the effect of tumor cell DNA content on recurrence in colorectal cancer. Cancer 67(10):2599–2604

    Article  PubMed  CAS  Google Scholar 

  19. Tang R, Ho YS, Chen HH, See LC, Wang JY (1998) Different prognostic effect of postoperative chemoradiation therapy on diploid and nondiploid high-risk rectal cancers. Dis Colon Rectum 41(12):1494–1499

    Article  PubMed  CAS  Google Scholar 

  20. Fleming I, Cooper J, Henson DE et al (1997) AJCC Cancer Staging Manual, 5th edn. Lippincot-Raven, Philadelphia

    Google Scholar 

  21. Auer GU, Caspersson TO, Wallgren AS (1980) DNA content and survival in mammary carcinoma. Anal Quant Cytol 2(3):161–165

    PubMed  CAS  Google Scholar 

  22. Risques RA, Moreno V, Ribas M, Marcuello E, Capella G, Peinado MA (2003) Genetic pathways and genome-wide determinants of clinical outcome in colorectal cancer. Cancer Res 63(21):7206–7214

    PubMed  CAS  Google Scholar 

  23. Salazar R, Roepman P, Capella G, Moreno V, Simon I, Dreezen C, Lopez-Doriga A, Santos C, Marijnen C, Westerga J, Bruin S, Kerr D, Kuppen P, van de Velde C, Morreau H, Van Velthuysen L, Glas AM, Van’t Veer LJ, Tollenaar R (2011) Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer. J Clin Oncol 29(1):17–24. doi:10.1200/JCO.2010.30.1077

    Article  PubMed  Google Scholar 

  24. Smith JJ, Deane NG, Wu F, Merchant NB, Zhang B, Jiang A, Lu P, Johnson JC, Schmidt C, Bailey CE, Eschrich S, Kis C, Levy S, Washington MK, Heslin MJ, Coffey RJ, Yeatman TJ, Shyr Y, Beauchamp RD (2010) Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology 138(3):958–968. doi:10.1053/j.gastro.2009.11.005

    Article  PubMed  CAS  Google Scholar 

  25. Heinzerling JH, Anthony T, Livingston EH, Huerta S (2007) Predictors of distant metastasis and mortality in patients with stage II colorectal cancer. Am Surg 73(3):230–238

    PubMed  Google Scholar 

  26. Kerr D, Gray R, Quirke P, Watson D, Yothers G, Lavery IC, Lee M, O’Connell MJ, Shak S, Wolmark N (2009) A quantitative multigene RT-PCR assay for prediction of recurrence in stage II colon cancer: selection of the genes in four large studies and results of the independent, prospectively designed QUASAR validation study. J Clin Oncol 27(15s):suppl; abstr 4000

    Google Scholar 

  27. Soreide K, Slewa A, Stokkeland PJ, van Diermen B, Janssen EA, Soreide JA, Baak JP, Korner H (2009) Microsatellite instability and DNA ploidy in colorectal cancer: potential implications for patients undergoing systematic surveillance after resection. Cancer 115(2):271–282. doi:10.1002/cncr.24024

    Article  PubMed  Google Scholar 

  28. Canna K, McArdle PA, McMillan DC, McNicol AM, Smith GW, McKee RF, McArdle CS (2005) The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Br J Cancer 92(4):651–654. doi:10.1038/sj.bjc.6602419

    Article  PubMed  CAS  Google Scholar 

  29. Takagawa R, Fujii S, Ohta M, Nagano Y, Kunisaki C, Yamagishi S, Osada S, Ichikawa Y, Shimada H (2008) Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer. Ann Surg Oncol 15(12):3433–3439. doi:10.1245/s10434-008-0168-8

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Grants from the Ad Infinitum Foundation, the Werner & Clara Kreitz Foundation, and the H.W. & J. Hector Foundation are gratefully acknowledged. This study was performed in collaboration with the “North German Tumorbank of Colorectal Cancer” (DKH #108446) and the “Surgical Center for Translational Oncology–Lübeck” (SCTO-L).

Conflict of interest

All authors declare that there is no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jens K. Habermann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Laubert, T., Bente, V., Freitag-Wolf, S. et al. Aneuploidy and elevated CEA indicate an increased risk for metachronous metastasis in colorectal cancer. Int J Colorectal Dis 28, 767–775 (2013). https://doi.org/10.1007/s00384-012-1625-1

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-012-1625-1

Keywords

Navigation